Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Osterheider

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Fortschritte Der Neurologie-Psychiatrie|June 1, 1995
[Trends in drug therapy of obsessive-compulsive disorders]M Osterheider
Fortschritte Der Neurologie-Psychiatrie|August 27, 2011
[Forensic-psychiatric assessment of pedophilia]J Nitschke, M Osterheider, A Mokros
Fortschritte Der Neurologie-Psychiatrie|February 1, 1989
[The Charles Bonnet syndrome]K Podoll, M Osterheider, J Noth
Der Nervenarzt|September 13, 2011
[Pedophilia. Prevalence, etiology, and diagnostics]A Mokros, M Osterheider, J Nitschke
Psychiatrische Praxis|April 8, 1998
[Total illness costs of schizophrenia and monetary evaluation of prevention of recurrence exemplified by a standard depot neuroleptic (flupenthixol decanoate)]M Osterheider, K Franken-Hiep, R Horn
Pharmacoepidemiology and Drug Safety|April 10, 2004
Fluoxetine treatment and single psychotropic comedication: is there an increase in adverse event rates?R W Dittmann, M Linden, M Osterheider
International Clinical Psychopharmacology|January 1, 1993
Three types of early termination of antidepressant drug treatmentM Linden, M Osterheider, T Nickelsen, et al.
Der Nervenarzt|April 3, 2010
[Forensic psychiatry and behavioural analysis]J Nitschke, D Schinke, B Ottermann, et al.
Psychopharmacology|January 1, 1991
Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorderK P Lesch, A Hoh, H M Schulte, et al.
Fortschritte Der Neurologie-Psychiatrie|November 24, 1998
[Positive and negative symptoms in chronic schizophrenic patients under maintenance therapy with flupenthixol decanoate for a twelve month perioid]J Pach, T Finkbeiner, T Glaser, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Fortschritte Der Neurologie-Psychiatrie|June 1, 1995
[Trends in drug therapy of obsessive-compulsive disorders]M Osterheider
Fortschritte Der Neurologie-Psychiatrie|August 27, 2011
[Forensic-psychiatric assessment of pedophilia]J Nitschke, M Osterheider, A Mokros
Fortschritte Der Neurologie-Psychiatrie|February 1, 1989
[The Charles Bonnet syndrome]K Podoll, M Osterheider, J Noth
Der Nervenarzt|September 13, 2011
[Pedophilia. Prevalence, etiology, and diagnostics]A Mokros, M Osterheider, J Nitschke
Psychiatrische Praxis|April 8, 1998
[Total illness costs of schizophrenia and monetary evaluation of prevention of recurrence exemplified by a standard depot neuroleptic (flupenthixol decanoate)]M Osterheider, K Franken-Hiep, R Horn
Pharmacoepidemiology and Drug Safety|April 10, 2004
Fluoxetine treatment and single psychotropic comedication: is there an increase in adverse event rates?R W Dittmann, M Linden, M Osterheider
International Clinical Psychopharmacology|January 1, 1993
Three types of early termination of antidepressant drug treatmentM Linden, M Osterheider, T Nickelsen, et al.
Der Nervenarzt|April 3, 2010
[Forensic psychiatry and behavioural analysis]J Nitschke, D Schinke, B Ottermann, et al.
Psychopharmacology|January 1, 1991
Long-term fluoxetine treatment decreases 5-HT1A receptor responsivity in obsessive-compulsive disorderK P Lesch, A Hoh, H M Schulte, et al.
Fortschritte Der Neurologie-Psychiatrie|November 24, 1998
[Positive and negative symptoms in chronic schizophrenic patients under maintenance therapy with flupenthixol decanoate for a twelve month perioid]J Pach, T Finkbeiner, T Glaser, et al.
Pageof 3